The study of 50 mothers and sons will trace the roots of risk for immune factors that can complicate treatment of the bleeding disorder.
A diverse, thorough dataset of a nearly 100,000 genome sequences is now available to scientists through the National Institutes of Health's All of Us Research Program.
The nearly 100,000 whole genome sequences reflect contributions from diverse participants.
Dr. Nickerson was a leading figure in applying genomic sequencing to advance precision medicine for diverse populations.
Catalyst for Precision Medicine Award recognizes his laboratory medicine advances in cancer testing and diagnostics.
National Human Genome Sciences Institute today launched a multi-center initiative to research how variations in DNA sequences confer disease risks.
A Nature paper today discusses findings from sequencing and data analysis of 53,581 diverse human genomes.
Sequencing expert Deborah Nickerson, from UW Medicine Genome Sciences and Brotman Baty Institute for Precision Medicine, explains initial findings.
Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies.
Your genes could help lead to better care for a patient in the future.
